deoxycytidine and phosphorylcholine

deoxycytidine has been researched along with phosphorylcholine in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Berger, MR; Georgieva, MC; Konstantinov, SM; Topashka-Ancheva, M	1
Bendell, JC; Campos, LT; Gardner, L; Hagenstad, C; Hermann, RC; Nemunaitis, J; Richards, DA; Sportelli, P; Vukelja, SJ	1
Anderson, KC; Eng, C; Hideshima, T; Kolesar, J; Richardson, PG	1
Chen, B; Cheng, L; Hong, DF; Shen, XD; Xin, Y	1
Câmara, AS; Faria, RC; Materon, EM; Nascimento, GF; Oliveira, ON; Sandrino, B; Shimizu, FM	1

Trials

1 trial(s) available for deoxycytidine and phosphorylcholine

Article	Year
Randomized placebo-controlled phase II trial of perifosine plus capecitabine as second- or third-line therapy in patients with metastatic colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Nov-20, Volume: 29, Issue:33 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Double-Blind Method; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Phosphorylcholine	2011

Article

Year

Randomized placebo-controlled phase II trial of perifosine plus capecitabine as second- or third-line therapy in patients with metastatic colorectal cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Nov-20, Volume: 29, Issue:33

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Double-Blind Method; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Phosphorylcholine

2011

Other Studies

4 other study(ies) available for deoxycytidine and phosphorylcholine

Article	Year
Combination effects of alkylphosphocholines and gemcitabine in malignant and normal hematopoietic cells. Cancer letters, 2002, Aug-28, Volume: 182, Issue:2 Topics: Antimetabolites, Antineoplastic; Apoptosis; Cell Survival; Cell-Free System; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Gemcitabine; Hematopoietic Stem Cells; HL-60 Cells; Humans; K562 Cells; Phosphorylcholine; Reference Values; Tumor Cells, Cultured	2002
Perifosine , an oral, anti-cancer agent and inhibitor of the Akt pathway: mechanistic actions, pharmacodynamics, pharmacokinetics, and clinical activity. Expert opinion on drug metabolism & toxicology, 2012, Volume: 8, Issue:5 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Capecitabine; Cell Line, Tumor; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Deoxycytidine; Dexamethasone; Drug Evaluation, Preclinical; Fluorouracil; Humans; Multiple Myeloma; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Pyrazines; Randomized Controlled Trials as Topic	2012
Perifosine inhibits S6K1-Gli1 signaling and enhances gemcitabine-induced anti-pancreatic cancer efficiency. Cancer chemotherapy and pharmacology, 2014, Volume: 73, Issue:4 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Deoxycytidine; Disease Progression; Dose-Response Relationship, Drug; Drug Synergism; Gemcitabine; Gene Knockdown Techniques; Humans; Male; Mice; Mice, SCID; Pancreatic Neoplasms; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Random Allocation; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Small Interfering; Signal Transduction; Survival Analysis; Transcription Factors; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1	2014
Role of sphingomyelin on the interaction of the anticancer drug gemcitabine hydrochloride with cell membrane models. Colloids and surfaces. B, Biointerfaces, 2020, Volume: 196 Topics: Antineoplastic Agents; Cell Membrane; Deoxycytidine; Gemcitabine; Glycerol; Phosphorylcholine; Sphingomyelins	2020